Evolution of the gut Amicrobiome during the pathogenesis of smoking-associated Kras-mutant lung cancer

被引：0

作者：

Treekitkarnmongkol, Warapen ^{[1
]}

Finnicum, Casey ^{[2
]}

Sinjab, Ansam ^{[1
]}

Hassane, Maya ^{[3
]}

Davis, Christel ^{[2
]}

Davies, Gareth E. ^{[2
]}

Hoffman, Kristi L. ^{[4
]}

Fujimoto, Junya ^{[1
]}

McAllister, Florencia ^{[1
]}

Sepesi, Boris ^{[1
]}

Cascone, Tina ^{[1
]}

Jenq, Robert R. ^{[1
]}

Petrosino, Joseph ^{[4
]}

Ehli, Erik ^{[2
]}

Moghaddam, Seyed J. ^{[1
]}

Kadara, Humam ^{[1
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

[2] Avera Inst Human Genet, Sioux Falls, SD USA

[3] Amer Univ Beirut, Beirut, Lebanon

[4] Baylor Coll Med, Houston, TX 77030 USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-3349

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3349

引用

页数：2

共 50 条

[21] An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer
Wang, Haiyun
Lv, Qi
Xu, Yue
Cai, Zhaoqing
Zheng, Jie
Cheng, Xiaojie
Dai, Yao
Janne, Pasi A.
Ambrogio, Chiara
Koehler, Jens
EBIOMEDICINE, 2019, 49 : 106 - 117
[22] The Gut Microbiome Promotes Tumorigenesis in Multiple Smoking-Associated Cancer Models
Kurtom, S.
Sharma, P.
Sethi, V.
Ferrantella, A.
Tao, J.
Jacob, H. K.
Roy, P.
Ramakrishnan, S.
Roy, S.
Saluja, A.
Dudeja, V.
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S23 - S23
[23] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer
Boumelha, Jesse
de Carne, Sophie
Romero, Pablo
Moliona, Miriam
Downward, Julian
CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
[24] Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
Aredo, J.
Padda, S.
Kunder, C.
Han, S.
Wakelee, H.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1133 - S1133
[25] Implication of targeting YAP1 in KRAS-mutant lung cancer cells.
Shimomura, Iwao
Yamamoto, Yusuke
Tada, Yuji
Tatsumi, Koichiro
Ochiya, Takahiro
MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 39 - 40
[26] Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutations
Davis, Alexander P.
Cooper, Wendy A.
Boyer, Michael
Lee, Jenny H.
Pavlakis, Nick
Kao, Steven C.
IMMUNOTHERAPY, 2021, 13 (11) : 941 - 952
[27] KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
Karimi, Nastaran
Moghaddam, Seyed Javad
CELLS, 2023, 12 (05)
[28] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
Abdel-Rahman, Omar
JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
[29] KRAS-Mutant non-small cell lung cancer: From biology to therapy
Ferrer, Irene
Zugazagoitia, Jon
Herbertz, Stephan
John, William
Paz-Ares, Luis
Schmid-Bindert, Gerald
LUNG CANCER, 2018, 124 : 53 - 64
[30] Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
Zhang, Jun
Park, Dongkyoo
Shin, Dong M.
Deng, Xingming
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 11 - 16

← 1 2 3 4 5 →